Search Results: Displaying all items (36)

First Author Title Journal Publication Date
Mukai S. Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infection. International journal of mycobacteriology 2017
Usdin M. Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017
Kowada A. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes. Epidemiology and infection 2016
Kowada A. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries. Travel medicine and infectious disease 2016
Auguste P. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation. Health technology assessment (Winchester, England) 2016
Belay M. IFN-γ and IgA against non-methylated heparin-binding hemagglutinin as markers of protective immunity and latent tuberculosis: Results of a longitudinal study from an endemic setting. The Journal of infection 2016
Çekiç C. Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy. Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology 2015
Dal Monte P. Does biological therapy affect IGRA response? A long-term follow-up of psoriatic patients using Quantiferon-TB. The British journal of dermatology 2014
Shim TS. Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy. Tuberculosis and respiratory diseases 2014
Gisondi P. Latent tuberculosis infection in patients with chronic plaque psoriasis candidate to biological therapy. The British journal of dermatology 2014
Hatzara C. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases. Annals of the rheumatic diseases 2014
Jung HJ. Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases. Rheumatology international 2014
Reichmann MT. Tuberculosis and TNF-inhibitors: history of exposure should outweigh investigations. BMJ case reports 2014
Gan SH. Interferon-γ responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus. The European respiratory journal 2014
Bourré-Tessier J. Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents. Clinical rheumatology 2014
Ang M. Prospective Head-to-Head Study Comparing Two Commercial Interferon-gamma Release Assays for the Diagnosis of Tuberculous Uveitis. American journal of ophthalmology 2014
Saraceno R. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers. Expert opinion on biological therapy 2013
Iqbal AZ. Cost-effectiveness of Using Quantiferon Gold (QFT-G)(®) versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis. Public health nursing (Boston, Mass.) 2013
Kowada A. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. The Journal of infection 2013
Nienhaus A. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC health services research 2011
Load More Results